Tech Company Financing Transactions
Sera Prognostics Funding Round
On 1/11/2017, Sera Prognostics announced $40 million in Series C funding from Laboratory Corporation of America and private investors.
Transaction Overview
Company Name
Announced On
1/11/2017
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series C
Investors
Laboratory Corporation of America (Lead Investor) (David King)
Proceeds Purpose
Proceeds from the Series C financing, which includes existing investors, enable Sera to continue building clinical evidence to support reimbursement and insurance coverage decisions, as well as expand commercialization nationwide for the PreTRM test.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
2749 East Parleys Way 200
Salt Lake City, UT 84109
USA
Salt Lake City, UT 84109
USA
Phone
Website
Email Address
Overview
Sera Prognostics, Inc., was founded in January 2008 to develop diagnostic tests for early prediction of preterm birth, preeclampsia and other pregnancy complications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gregory Critchfield
Chief Financial Officer
Jay Moyes
Chief Information Officer
Robert Harrison
Chief Scientific Officer
Jay Boniface
Vice President
Thomas Garite
VP - Bus. Development
Nadia Altomare
VP - Bus. Development
Douglas Fisher
VP - General Counsel
Benjamin Jackson
Browse more venture capital transactions:
Prev: 1/11/2017: Trackforce venture capital transaction
Next: 1/11/2017: Lalamove venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs